![Xin He](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xin He
Director/Board Member at BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION
Profile
Xin He is the founder of RHEI Pharmaceuticals, Inc. He is currently serving as the Director at Elpiscience Biopharma Ltd.
Additionally, he holds the position of Independent Non-Executive Director at Biosino Bio-Technology & Science, Inc. since 2024.
Dr. He is also a Non-Executive Director at Elpiscience Biopharmaceuticals, Inc. since 2019.
He completed his graduate degree at Princeton University.
Xin He active positions
Companies | Position | Start |
---|---|---|
BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION | Director/Board Member | 27/06/2024 |
Elpiscience Biopharma Ltd.
![]() Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Director/Board Member | - |
Elpiscience Biopharmaceuticals, Inc.
![]() Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Elpiscience Biopharmaceuticals, Inc. is an investment holding company, which engages in the research and development of immuno-oncology therapies. It focuses on the development of clinical-stage drug candidates namely, ES102, ES014, ES104, and ES009. The company was founded by Xiao Hui Ji and Hong Tao Lu in June 2017 and is headquartered in Shanghai, China. | Director/Board Member | 27/12/2019 |
Former positions of Xin He
Companies | Position | End |
---|---|---|
RHEI Pharmaceuticals, Inc.
![]() RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Chief Executive Officer | - |
Training of Xin He
Yale University | Doctorate Degree |
Princeton University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION | Health Technology |
Private companies | 3 |
---|---|
RHEI Pharmaceuticals, Inc.
![]() RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Health Technology |
Elpiscience Biopharma Ltd.
![]() Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
Elpiscience Biopharmaceuticals, Inc.
![]() Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Elpiscience Biopharmaceuticals, Inc. is an investment holding company, which engages in the research and development of immuno-oncology therapies. It focuses on the development of clinical-stage drug candidates namely, ES102, ES014, ES104, and ES009. The company was founded by Xiao Hui Ji and Hong Tao Lu in June 2017 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Xin He